Mumbai-based Emcure Pharmaceuticals’ subsidiary Emcutix Biopharmaceuticals has partnered with WiQo to introduce PRX-PLUS, an advanced skin rejuvenation solution in India. This collaboration brings cutting-edge derma-cosmetic innovation to the growing aesthetic market. This collaboration brings PRX-PLUS which is a next-generation, non-invasive skin booster to India. It delivers visible tightening and rejuvenation without needles, pain, or downtime. Also, as demand for advanced, ...
Emcure Pharmaceuticals has introduced Emcutix Biopharmaceuticals, a wholly-owned subsidiary focused entirely on dermatology. This new venture aims to expand Emcure’s portfolio by offering innovative dermatology solutions that address both therapeutic and aesthetic skin care needs. Leveraging Emcure’s strong presence in the healthcare industry, the company will provide advanced dermatological products that enhance the skincare market in India. Moreover, the subsidiary ...